XML 65 R54.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Combinations (Baxalta Assets Acquired and Liabilities Assumed) (Details) - USD ($)
$ in Millions
Jun. 03, 2016
Sep. 30, 2016
Dec. 31, 2015
Sep. 30, 2015
Dec. 31, 2014
Current assets:          
Goodwill   $ 14,850.6 $ 4,147.8 $ 4,289.6 $ 2,474.9
Baxalta          
Current assets:          
Cash and cash equivalents $ 583.2        
Accounts receivable, net 1,399.8        
Inventories 5,064.7        
Other current assets 362.2        
Total current assets 7,409.9        
Property, plant and equipment, net 5,569.3        
Investments 128.2        
Goodwill 8,001.0        
Other non-current assets 103.3        
Total assets 46,923.9        
Current liabilities:          
Accounts payable and accrued expenses 1,537.0        
Other current liabilities 92.9        
Long-term borrowings 5,424.9        
Deferred tax liability 6,385.3        
Other non-current liabilities 1,105.3        
Total liabilities 14,545.4        
Preliminary fair value of identifiable assets acquired and liabilities assumed 32,378.5        
Preliminary fair value of purchase consideration 32,378.5        
Currently marketed products | Baxalta          
Current assets:          
Other intangible assets, net 24,150.0        
In-Process Research and Development (IPR&D) | Baxalta          
Current assets:          
Other intangible assets, net 1,480.0        
Contract based arrangements | Baxalta          
Current assets:          
Other intangible assets, net 82.2        
Preliminary values | Baxalta          
Current assets:          
Cash and cash equivalents 583.2        
Accounts receivable, net 1,382.8        
Inventories 5,341.1        
Other current assets 362.2        
Total current assets 7,669.3        
Property, plant and equipment, net 5,687.7        
Investments 128.2        
Goodwill 6,106.4        
Other non-current assets 103.3        
Total assets 47,257.1        
Current liabilities:          
Accounts payable and accrued expenses 1,509.5        
Other current liabilities 15.4        
Long-term borrowings 5,424.9        
Deferred tax liability 6,831.7        
Other non-current liabilities 1,092.1        
Total liabilities 14,873.6        
Preliminary fair value of identifiable assets acquired and liabilities assumed 32,383.5        
Preliminary fair value of purchase consideration 32,383.5        
Preliminary values | Currently marketed products | Baxalta          
Current assets:          
Other intangible assets, net 24,550.0        
Preliminary values | In-Process Research and Development (IPR&D) | Baxalta          
Current assets:          
Other intangible assets, net 2,940.0        
Preliminary values | Contract based arrangements | Baxalta          
Current assets:          
Other intangible assets, net 72.2        
Measurement period adjustments | Baxalta          
Current assets:          
Cash and cash equivalents 0.0        
Accounts receivable, net 17.0        
Inventories (276.4)        
Other current assets 0.0        
Total current assets (259.4)        
Property, plant and equipment, net (118.4)        
Investments 0.0        
Goodwill 1,894.6        
Other non-current assets 0.0        
Total assets (333.2)        
Current liabilities:          
Accounts payable and accrued expenses 27.5        
Other current liabilities 77.5        
Long-term borrowings 0.0        
Deferred tax liability (446.4)        
Other non-current liabilities 13.2        
Total liabilities (328.2)        
Preliminary fair value of identifiable assets acquired and liabilities assumed (5.0)        
Preliminary fair value of purchase consideration (5.0)        
Measurement period adjustments | Currently marketed products | Baxalta          
Current assets:          
Other intangible assets, net (400.0)        
Measurement period adjustments | In-Process Research and Development (IPR&D) | Baxalta          
Current assets:          
Other intangible assets, net (1,460.0)        
Measurement period adjustments | Contract based arrangements | Baxalta          
Current assets:          
Other intangible assets, net $ 10.0